Rocket One Inc. Restricted Cash Equivalents
Rocket One Inc. (RKTO) had Restricted Cash Equivalents of $200.00 thousand as of 2020-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashEquivalents · last filed 2021-05-13
- 2020-03-31: Restricted Cash Equivalents $200.00K.
- 2019-12-31: Restricted Cash Equivalents $200.00K.
- 2019-09-30: Restricted Cash Equivalents $200.00K.
- 2019-06-30: Restricted Cash Equivalents $200.00K.
| Period end | Restricted Cash Equivalents |
|---|---|
| 2020-03-31 | $200.00K 10-Q · filed 2021-05-13 |
| 2019-12-31 | $200.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $200.00K 10-Q · filed 2020-11-10 |
| 2019-06-30 | $200.00K 10-Q · filed 2020-08-13 |
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |